Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 94 (5) , 534-538
- https://doi.org/10.1016/s1081-1206(10)61129-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Anaphylaxis in the Asia PacificAllergy & Clinical Immunology International - Journal of the World Allergy Organization, 2004
- Adrenaline in the treatment of anaphylaxis: what is the evidence?BMJ, 2003
- Use of injections in healthcare settings worldwide, 2000: literature review and regional estimatesBMJ, 2003
- Epinephrine dispensing patterns for an out-of-hospital population: A novel approach to studying the epidemiology of anaphylaxisJournal of Allergy and Clinical Immunology, 2002
- Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: Is the ampule/syringe/needle method practical?Journal of Allergy and Clinical Immunology, 2001
- Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based studyAnnals of Allergy, Asthma & Immunology, 2001
- First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen)Journal of Allergy and Clinical Immunology, 2000
- Epidemiology of anaphylaxis in Olmsted County: A population-based study☆☆☆★★★Journal of Allergy and Clinical Immunology, 1999
- Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAACThe Lancet, 1998
- Fatal Systemic Anaphylaxis in ManNew England Journal of Medicine, 1964